How Can Mitochondrial Dna Deletions Act As A Biomarker for the Detection of Endometriosis Within the Clinic?

Abstract excerpt

these features of the mitochondrial genome, its mutated subtypes and especially large-scale deletions, potentially resolve limitations of endometriosis biomarkers of different origins and offer the promise of successful translation to clinical application.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Endometrial and Cervical Cancer Treatments
• Share to Endometriosis Research and Treatment
• Share to Reproductive System and Pregnancy